Martin J B Taphoorn

Summary

Affiliation: The Hague
Country: The Netherlands

Publications

  1. ncbi Review on quality of life issues in patients with primary brain tumors
    Martin J B Taphoorn
    VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
    Oncologist 15:618-26. 2010
  2. ncbi Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial
    Martin J B Taphoorn
    Department of Neurology, Medical Center Haaglanden Westeinde Ziekenhuis, The Hague, The Netherlands
    J Clin Oncol 25:5723-30. 2007
  3. ncbi Health-related quality of life in patients with glioblastoma: a randomised controlled trial
    Martin J B Taphoorn
    Medical Centre Haaglanden, The Hague, The Netherlands
    Lancet Oncol 6:937-44. 2005
  4. ncbi Cognitive deficits in adult patients with brain tumours
    Martin J B Taphoorn
    Department of Neurology, Medical Centre Haaglanden, The Hague, Netherlands
    Lancet Neurol 3:159-68. 2004
  5. ncbi An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
    Martin J B Taphoorn
    Medical Centre Haaglanden, The Hague and VU University Medical Centre Amsterdam, The Netherlands
    Eur J Cancer 46:1033-40. 2010
  6. ncbi Health-related quality of life of long-term high-grade glioma survivors
    Ingeborg Bosma
    VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
    Neuro Oncol 11:51-8. 2009
  7. ncbi Decision-making in the end-of-life phase of high-grade glioma patients
    Eefje M Sizoo
    Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
    Eur J Cancer 48:226-32. 2012
  8. ncbi The course of neurocognitive functioning in high-grade glioma patients
    Ingeborg Bosma
    Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Neuro Oncol 9:53-62. 2007
  9. ncbi Symptoms and problems in the end-of-life phase of high-grade glioma patients
    Eefje M Sizoo
    Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Neuro Oncol 12:1162-6. 2010
  10. ncbi [Course of disease and treatment policy in suspected low-grade glioma]
    Eefje M Sizoo
    VU Medisch Centrum, afd Neurologie, Amsterdam, The Netherlands
    Ned Tijdschr Geneeskd 154:A1367. 2010

Detail Information

Publications25

  1. ncbi Review on quality of life issues in patients with primary brain tumors
    Martin J B Taphoorn
    VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
    Oncologist 15:618-26. 2010
    ..In clinical practice, assessing HRQOL may be helpful in the communication between doctor and patient and may facilitate treatment decisions...
  2. ncbi Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial
    Martin J B Taphoorn
    Department of Neurology, Medical Center Haaglanden Westeinde Ziekenhuis, The Hague, The Netherlands
    J Clin Oncol 25:5723-30. 2007
    ....
  3. ncbi Health-related quality of life in patients with glioblastoma: a randomised controlled trial
    Martin J B Taphoorn
    Medical Centre Haaglanden, The Hague, The Netherlands
    Lancet Oncol 6:937-44. 2005
    ..This paper reports the health-related quality of life (HRQOL) of the patients in this trial...
  4. ncbi Cognitive deficits in adult patients with brain tumours
    Martin J B Taphoorn
    Department of Neurology, Medical Centre Haaglanden, The Hague, Netherlands
    Lancet Neurol 3:159-68. 2004
    ..Cognitive function is now also recognised as an independent prognostic factor in the survival of glioma patients. Additionally, cognitive deterioration can be the first indicator of progressive disease after treatment...
  5. ncbi An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
    Martin J B Taphoorn
    Medical Centre Haaglanden, The Hague and VU University Medical Centre Amsterdam, The Netherlands
    Eur J Cancer 46:1033-40. 2010
    ..This study examined the validity and reliability of the questionnaire in a multi-national, multi-lingual study...
  6. ncbi Health-related quality of life of long-term high-grade glioma survivors
    Ingeborg Bosma
    VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
    Neuro Oncol 11:51-8. 2009
    ..We concluded that baseline HRQOL is not related to duration of survival and that long-term survivors show improvement of HRQOL to a level comparable to that of the healthy...
  7. ncbi Decision-making in the end-of-life phase of high-grade glioma patients
    Eefje M Sizoo
    Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
    Eur J Cancer 48:226-32. 2012
    ..In this study the ELD-making process in HGG patients is described...
  8. ncbi The course of neurocognitive functioning in high-grade glioma patients
    Ingeborg Bosma
    Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Neuro Oncol 9:53-62. 2007
    ..The possibility of deleterious effects is important to consider when prescribing antiepileptic drug treatment...
  9. ncbi Symptoms and problems in the end-of-life phase of high-grade glioma patients
    Eefje M Sizoo
    Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Neuro Oncol 12:1162-6. 2010
    ..Our study demonstrates that HGG patients, unlike the general cancer population, have specific symptoms in the end-of-life phase. Further research is needed in order to develop specific palliative care guidelines for these patients...
  10. ncbi [Course of disease and treatment policy in suspected low-grade glioma]
    Eefje M Sizoo
    VU Medisch Centrum, afd Neurologie, Amsterdam, The Netherlands
    Ned Tijdschr Geneeskd 154:A1367. 2010
    ..Each patient in whom a low-grade glioma is suspected should receive specific treatment advice from a neuro-oncological team...
  11. ncbi Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life
    Martin Klein
    Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands
    Ann Neurol 54:514-20. 2003
    ..In conclusion, low-grade glioma patients suffer from a number of neuropsychological and psychological problems that are aggravated by the severity of epilepsy and by the intensity of the treatment...
  12. ncbi Management of temozolomide toxicity by nurse practitioners in neuro-oncology
    Hanneke Zwinkels
    Department of Neurology, Medical Centre Haaglanden, Netherlands
    Oncol Nurs Forum 36:225-31. 2009
    ..To investigate the toxicity of temozolomide (TMZ) in patients with brain tumors and appropriate nursing interventions...
  13. ncbi Interventions for cognitive deficits in adults with brain tumours
    Karin Gehring
    Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands
    Lancet Neurol 7:548-60. 2008
    ..Finally, we describe studies in patients with cancers outside the CNS, to highlight further possibilities for the prevention and treatment of cognitive deficits...
  14. ncbi SMART syndrome: a late reversible complication after radiation therapy for brain tumours
    Joost P Kerklaan
    Department of Neurology, Medical Centre Haaglanden, Postbus 432, 2501 CK, The Hague, The Netherlands
    J Neurol 258:1098-104. 2011
    ..Before the diagnosis of SMART syndrome can be established other causes, such as local tumour recurrence, leptomeningeal disease or ischemic disease should be ruled out...
  15. ncbi Symptomatic management and imaging of brain metastases
    Evert C A Kaal
    Department of Neurology, Medical Center Haaglanden, P.O. Box 432, 2501, CK, The Hague, Netherlands
    J Neurooncol 75:15-20. 2005
    ..The risk on vascular complications in patients with brain metastases is increased and needs special attention. Treatment of psychiatric complications e.g. delirium or depression may also improve quality of life...
  16. ncbi Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study
    Murielle E L Mauer
    European Organisation for Research and Treatment of Cancer Data Center, Quality of Life Unit, Ave Mounier 83 11, Brussels, Belgium 1200
    J Clin Oncol 25:5731-7. 2007
    ..This is one of a few studies that have explored the value of baseline symptoms and health-related quality of life (HRQOL) in predicting survival in patients with brain cancer...
  17. ncbi 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
    Mathilde C M Kouwenhoven
    Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
    Eur J Cancer 42:2499-503. 2006
    ..Responses to first line temozolomide are strongly correlated to loss of 1p. Response to second line alkylating treatment is modest even in tumours with 1p/19q loss. For further improvement of outcome in OD novel treatments are needed...
  18. ncbi Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer p
    Martin J van den Bent
    Departments of Neurology and Pathology, Daniel den Hoed Cancer Center Erasmus University Hospital, Rotterdam, The Netherlands
    J Clin Oncol 24:2715-22. 2006
    ....
  19. ncbi Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Roger Stupp
    Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    N Engl J Med 352:987-96. 2005
    ..In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and safety...
  20. ncbi Neurocognitive sequelae in the treatment of low-grade gliomas
    Martin J B Taphoorn
    Department of Neurology/Neuro-Oncology G03.228, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Semin Oncol 30:45-8. 2003
    ..This and other studies suggest that disease and treatment factors other than standard focal RT may be more important with respect to increasing the risk of neurocognitive sequelae in patients with low-grade gliomas...
  21. ncbi Impact of brain tumour treatment on quality of life
    Jan J Heimans
    VU Medical Centre Department of Neurology P O Box 7057, 1007 MB Amsterdam, The Netherlands
    J Neurol 249:955-60. 2002
    ....
  22. ncbi Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial
    Peter W A Willems
    Department of Neurosurgery, University Medical Center Utrecht, The Netherlands
    J Neurosurg 104:360-8. 2006
    ....
  23. ncbi Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases
    Dieta Brandsma
    Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
    Neuro Oncol 8:127-36. 2006
    ..We argue that an aberrantly regulated inside-out signaling pathway underlies constitutive integrin activation on the adherent leukemic cell population...
  24. ncbi The diagnostic difficulties of meningeal and intracerebral plasma cell granulomas--presentation of three cases
    Dieta Brandsma
    Dept of Neurology, G03 228, University Medical Center Utrecht, 85500, 3584 CX, Utrecht, The Netherlands
    J Neurol 250:1302-6. 2003
    ..These cases show the importance of diagnosing a meningeal or intracerebral plasma cell granuloma correctly, since it has both therapeutical and prognostic implications...
  25. ncbi Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review)
    Marco van Vulpen
    Department of Radiotherapy, Q 00 118, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands
    Oncol Rep 9:683-8. 2002
    ..We present a review on the effects of irradiation on the BBB and subsequently discuss the potential value for therapeutic applications...